Viewing Study NCT02893995

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:07 PM
Ignite Modification Date: 2026-02-22 @ 10:26 PM
Study NCT ID: NCT02893995
Status: WITHDRAWN
Last Update Posted: 2017-05-09
First Post: 2016-08-24
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety, Tolerability, Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin® Dose Titration in Pulmonary Arterial Hypertension
Sponsor: United Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pulmonary Arterial Hypertension View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PAH View
None Subcutaneous Treprostinil View
None Remodulin View
None 6 Minute Walk Test View